Gregorino Paone
- Use of discriminant analysis to assess pulmonary functional worsening in patients with sarcoidosis by means of a panel of inflammatory markersBy Gregorino Paone, Maria Rulli, Alessandro Belli, Armanda Propati, Angelo Sbrocca, Salvatore D'Antonio, Alfredo Sebastiani, Giovanni Puglisi, Giovanni Galluccio and Sandro BatzellaGregorino PaoneMaria Rulli3Department of Respiratory Diseases, S.Camillo-Forlanini Hospital, Rome, ItalyAlessandro Belli3Department of Respiratory Diseases, S.Camillo-Forlanini Hospital, Rome, ItalyArmanda Propati3Department of Respiratory Diseases, S.Camillo-Forlanini Hospital, Rome, ItalyAngelo Sbrocca3Department of Respiratory Diseases, S.Camillo-Forlanini Hospital, Rome, ItalySalvatore D'Antonio3Department of Respiratory Diseases, S.Camillo-Forlanini Hospital, Rome, ItalyAlfredo Sebastiani3Department of Respiratory Diseases, S.Camillo-Forlanini Hospital, Rome, ItalyGiovanni Puglisi3Department of Respiratory Diseases, S.Camillo-Forlanini Hospital, Rome, ItalyGiovanni Galluccio3Department of Respiratory Diseases, S.Camillo-Forlanini Hospital, Rome, ItalySandro Batzella3Department of Respiratory Diseases, S.Camillo-Forlanini Hospital, Rome, Italy
- Human neutrophil peptides as biomarkers for monitoring respiratory functional impairment in sarcoidosisBy Gregorino Paone, Maria Rulli, Alvaro Leone, Paolo Graziano, Vittoria Conti, Ilio Cammarella, Giovanni Galluccio, Alfredo Sebastiani, Gabriele Lucantoni and Giovanni PuglisiGregorino PaoneMaria Rulli3Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Rome, ItalyAlvaro Leone3Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Rome, ItalyPaolo Graziano3Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Rome, ItalyVittoria Conti1Department of Cardiovascular, Respiratory, Nephrological and Geriatric Sciences, “La Sapienza” S.Camillo-Forlanini Hospital, Roma, ItalyIlio Cammarella4Attilio Reali, “La Sapienza” S.Camillo-Forlanini Hospital, Rome, ItalyGiovanni Galluccio3Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Rome, ItalyAlfredo Sebastiani3Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Rome, ItalyGabriele Lucantoni3Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Rome, ItalyGiovanni Puglisi3Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Rome, Italy
- Usefulness of a panel of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patientsBy Gregorino Paone, Vittoria Conti, Alvaro Leone, Maria Rulli, Annarita Vestri, Giovanni Puglisi, Fulvio Benassi, Ilio Cammarella, Alfredo Sebastiani and Claudio TerzanoGregorino Paone1Department of Cardiovascular, Respiratory, Nephrological and Geriatric Sciences, “Sapienza” University of Rome; S. Camillo-Forlanini Hospital, Rome, ItalyVittoria Conti2Department of Cardiovascular, Respiratory, Nephrological and Geriatric Sciences, “Sapienza” University of Rome; Fondazione E. Lorillard Spencer Cenci, Rome, ItalyAlvaro Leone3Pathology Unit, S. Camillo-Forlanini Hospital, Rome, ItalyMaria Rulli1Department of Cardiovascular, Respiratory, Nephrological and Geriatric Sciences, “Sapienza” University of Rome; S. Camillo-Forlanini Hospital, Rome, ItalyAnnarita Vestri4Department of Public Health and Infectious Diseases, “Sapienza” University of Rome, Rome, ItalyGiovanni Puglisi5Unit of Pulmonology and Respiratory Infectious Diseases, S. Camillo-Forlanini Hospital, Rome, ItalyFulvio Benassi6Unit of Respiratory Failure and Rehabilitation, S. Camillo-Forlanini Hospital, Rome, ItalyIlio Cammarella7Department “Attilio Reali”, “Sapienza” University of Rome, Rome, ItalyAlfredo Sebastiani5Unit of Pulmonology and Respiratory Infectious Diseases, S. Camillo-Forlanini Hospital, Rome, ItalyClaudio Terzano2Department of Cardiovascular, Respiratory, Nephrological and Geriatric Sciences, “Sapienza” University of Rome; Fondazione E. Lorillard Spencer Cenci, Rome, Italy
- Human neutrophil peptides as biotracers of functional impairment in COPD smokersBy Gregorino Paone, Giovanni Schmid, Vittoria Conti, Fulvio Benassi, Gilda Giannunzio and Giovanni PuglisiGregorino Paone1Department of Cardiovascular, Respiratory, Nephrologic and Geriatric Sciences, University “La Sapienza”, Rome, ItalyGiovanni Schmid2S. Maria della Pace, IRCCS Don Gnocchi Foundation, Rome, ItalyVittoria Conti1Department of Cardiovascular, Respiratory, Nephrologic and Geriatric Sciences, University “La Sapienza”, Rome, ItalyFulvio Benassi3Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Rome, ItalyGilda Giannunzio3Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Rome, ItalyGiovanni Puglisi3Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Rome, Italy
- A combinational approach to optimize biomarkers efficacy in identifying patients with sarcoidosis and monitoring respiratory functional worseningBy Gregorino Paone, Gian Luca Di Tanna, Sandro Batzella, Francesco Belli, Salvatore D'Antonio, Mario Giuseppe Alma, Giovanni Schmid, Giovanni Puglisi and Annarita VestriGregorino Paone1Department of Cardiovascular, Respiratory, Nephrologic and Geriatric Sciences, University “La Sapienza”, Rome, ItalyGian Luca Di Tanna2Department of Public Health and Infectious Diseases, University “La Sapienza”, Rome, ItalySandro Batzella3Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Rome, ItalyFrancesco Belli3Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Rome, ItalySalvatore D'Antonio3Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Rome, ItalyMario Giuseppe Alma3Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Rome, ItalyGiovanni Schmid4S. Maria della Pace, IRCCS Don Gnocchi Foundation, Rome, ItalyGiovanni Puglisi3Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Rome, ItalyAnnarita Vestri2Department of Public Health and Infectious Diseases, University “La Sapienza”, Rome, Italy
- Effects of long term home NIV on lung inflammation in stable COPDBy Gregorino Paone, Vittoria Conti, Corrado Mollica, Patrizio Palermo, Ilio Cammarella, Giuseppe Brunetti, Gianluca Monaco, Gilda Giannunzio, Giovanni Puglisi and Giacomo FratiGregorino Paone1Heart and Lung Institute, Sapienza University of Rome, S. Camillo-Forlanini Hospital, Rome, ItalyVittoria Conti2Heart and Lung Institute, Respiratory Diseases Unit, School of Specialization of Respiratory Diseases, Sapienza University of Rome, Rome, Italy3Department of Respiratory Diseases, IRCCS San Raffaele - Pisana, Rome, ItalyCorrado Mollica4Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Rome, ItalyPatrizio Palermo1Heart and Lung Institute, Sapienza University of Rome, S. Camillo-Forlanini Hospital, Rome, ItalyIlio Cammarella1Heart and Lung Institute, Sapienza University of Rome, S. Camillo-Forlanini Hospital, Rome, ItalyGiuseppe Brunetti4Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Rome, ItalyGianluca Monaco4Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Rome, ItalyGilda Giannunzio4Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Rome, ItalyGiovanni Puglisi4Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Rome, ItalyGiacomo Frati5Department of Medical Surgical Sciences and Biotechnology, Sapienza University, Latina, Italy6Department of Angiocardioneurology, IRCCS "Neuromed", Pozzilli (IS), Italy
- Improved performances of the Quantiferon-TB in tube assay with novel mycobacterium tuberculosis specific antigenic peptidesBy Monica Losi, Ashley Knights, Francesca Mariani, Alfonso Altieri, Gregorino Paone, Vittorio Colizzi, Cesare Saltini, Jeff Boyle and Massimo AmicosanteMonica Losi1Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, ItalyAshley Knights2Research and Development, Cellestis - Qiagen, Chadstone, AustraliaFrancesca Mariani3Institute of Cell Biology and Neurobiology, National Research Council, Rome, ItalyAlfonso Altieri4Broncopneumologia e Tisiologia, Azienda Ospedaliera San Camillo Forlanini, Rome, ItalyGregorino Paone5Pulmonary Diseases, University of Rome "La Sapienza, Rome, ItalyVittorio Colizzi6Biology, University of Rome "Tor Vergata", Rome, ItalyCesare Saltini1Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, ItalyJeff Boyle2Research and Development, Cellestis - Qiagen, Chadstone, AustraliaMassimo Amicosante1Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy
- Predictors of outcome for patients with severe hypercapnic respiratory failure requiring NIVBy Vittoria Conti, Gregorino Paone, Corrado Mollica, Alfredo Sebastiani, Patrizio Palermo, Alice Mannocci, Giuseppe La Torre and Claudio TerzanoVittoria Conti1Heart and Lung Institute, Respiratory Diseases Unit, School of Specialization of Respiratory Diseases, Sapienza University of Rome, Rome, Italy2Department of Respiratory Diseases, IRCCS San Raffaele - Pisana, Rome, ItalyGregorino Paone3Heart and Lung Institute, Sapienza University of Rome, S.Camillo-Forlanini Hospital, Rome, ItalyCorrado Mollica4Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Rome, ItalyAlfredo Sebastiani4Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Rome, ItalyPatrizio Palermo3Heart and Lung Institute, Sapienza University of Rome, S.Camillo-Forlanini Hospital, Rome, ItalyAlice Mannocci5Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, ItalyGiuseppe La Torre5Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, ItalyClaudio Terzano1Heart and Lung Institute, Respiratory Diseases Unit, School of Specialization of Respiratory Diseases, Sapienza University of Rome, Rome, Italy
- A prospective study of the effect of carbocysteine lysine salt on COPD exacerbations with or without inhaled steroidsBy Gregorino Paone, Luigi Lanata, Patrizio Palermo, Michela Bagnasco, Simona Toti, Federico Saibene, Barbara Moscatelli, Alessandra Monguzzi and Giovanni PuglisiGregorino Paone1Department of Medicine, Respiratory Disease Section, San Camillo Forlanini Hospital, Rome, ItalyLuigi Lanata2Medical Department, Dompé SpA, Milan, ItalyPatrizio Palermo1Department of Medicine, Respiratory Disease Section, San Camillo Forlanini Hospital, Rome, ItalyMichela Bagnasco2Medical Department, Dompé SpA, Milan, ItalySimona Toti1Department of Medicine, Respiratory Disease Section, San Camillo Forlanini Hospital, Rome, ItalyFederico Saibene2Medical Department, Dompé SpA, Milan, ItalyBarbara Moscatelli3Department of Medicine, Respiratory Disease Section, Fatebenefratelli, Isola Tiberina Hospital, Rome, ItalyAlessandra Monguzzi2Medical Department, Dompé SpA, Milan, ItalyGiovanni Puglisi1Department of Medicine, Respiratory Disease Section, San Camillo Forlanini Hospital, Rome, Italy
- Pan-genomic and immunomic identification of novel mycobacterium tuberculosis antigens for TB diagnosisBy Carmela Gallo, Alessia Del Duca, Monica Losi, Alba Grifoni, Roberta Bernardini, Alfonso Altieri, Gregorino Paone, Maurizio Mattei, Cesare Saltini and Massimo AmicosanteCarmela Gallo1Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy2Animal Technology Station, University of Rome "Tor Vergata", Rome, ItalyAlessia Del Duca1Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy2Animal Technology Station, University of Rome "Tor Vergata", Rome, ItalyMonica Losi1Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, ItalyAlba Grifoni3R&D, ProxAgen Ltd., Sofia, BulgariaRoberta Bernardini2Animal Technology Station, University of Rome "Tor Vergata", Rome, ItalyAlfonso Altieri4Broncopneumologia e Tisiologia, Azienda Ospedaliera San Camillo Forlanini, Rome, ItalyGregorino Paone5Pulmonary Diseases, University of Rome "La Sapienza", Rome, ItalyMaurizio Mattei2Animal Technology Station, University of Rome "Tor Vergata", Rome, ItalyCesare Saltini1Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, ItalyMassimo Amicosante1Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy3R&D, ProxAgen Ltd., Sofia, Bulgaria
- Effects of pulmonary rehabilitation in COPD patients treated with different pharmacological associationsBy Vittoria Conti, Eirini Lemontzi, Aliaksei Kisialiou, Stefano Bonassi, Gregorino Paone, Maurizio Volterrani, Giuseppe Caminiti and Vittorio CardaciVittoria Conti1Unit of Pulmonary Rehabilitation, IRCCS San Raffaele - Pisana, Rome, ItalyEirini Lemontzi1Unit of Pulmonary Rehabilitation, IRCCS San Raffaele - Pisana, Rome, ItalyAliaksei Kisialiou2Clinical and Molecular Epidemiology Unit, IRCCS San Raffaele - Pisana, Rome, ItalyStefano Bonassi2Clinical and Molecular Epidemiology Unit, IRCCS San Raffaele - Pisana, Rome, ItalyGregorino Paone3Heart and Lung Institute, Sapienza University of Rome, S. Camillo-Forlanini Hospital, Rome, ItalyMaurizio Volterrani4Unit of Cardiologic Rehabilitation, IRCCS San Raffaele - Pisana, Rome, ItalyGiuseppe Caminiti4Unit of Cardiologic Rehabilitation, IRCCS San Raffaele - Pisana, Rome, ItalyVittorio Cardaci1Unit of Pulmonary Rehabilitation, IRCCS San Raffaele - Pisana, Rome, Italy
- Non tuberculous mycobacteria (NTM) contamination in a hospital water supply network: Association with pulmonary infection in respiratory wardsBy Salvatore D'Antonio, Daniela Orazi, Elisabetta Magini, Alfonso Altieri, Mario Giuseppe Alma, Giovanni Puglisi, Isabella Sanguigni, Rita De santis and Gregorino PaoneSalvatore D'Antonio1Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Rome, ItalyDaniela Orazi2Direction, S. Camillo-Forlanini Hospital, Rome, ItalyElisabetta Magini3Microbiology and Virology Laboratory, S. Camillo-Forlanini Hospital, Rome, ItalyAlfonso Altieri1Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Rome, ItalyMario Giuseppe Alma1Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Rome, ItalyGiovanni Puglisi1Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Rome, ItalyIsabella Sanguigni3Microbiology and Virology Laboratory, S. Camillo-Forlanini Hospital, Rome, ItalyRita De santis1Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Rome, ItalyGregorino Paone4Department of Cardiovascular, Respiratory, Nephrologic Anesthesiologic and Geriatric Sciences, Sapienza' University, Rome, Italy
- QuantiFERON-TB performance enhanced by novel Mycobacterium tuberculosis-specific antigensBy Monica Losi, Ashley J. Knights, Francesca Mariani, Alfonso M. Altieri, Gregorino Paone, Andre G. Loxton, Novel N. Chegou, John Kenneth, Mario G. Alma, Vittorio Colizzi, Gerhard Walzl, Cesare Saltini, Jeff Boyle and Massimo AmicosanteArticle | Published in 2015 in European Respiratory JournalMonica Losi1Dept of Biomedicine and Prevention, University of Rome “Tor Vergata”, Rome, ItalyAshley J. Knights2QIAGEN Sciences LLC, Germantown, MD, USAFrancesca Mariani3Institute of Cell Biology and Neurobiology, National Research Council, Rome, ItalyAlfonso M. Altieri4Broncopneumologia e Tisiologia, Azienda Ospedaliera San Camillo Forlanini, Rome, ItalyGregorino Paone5Dept of Cardiovascular, Respiratory, Nephrologic, Anesthesiologic and Geriatric Sciences, University of Rome “La Sapienza”, Rome, ItalyAndre G. Loxton6SA MRC Centre for TB Research, DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South AfricaNovel N. Chegou6SA MRC Centre for TB Research, DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South AfricaJohn Kenneth7Division of Infectious Diseases, St John's Research Institute, St John's National Academy of Health Sciences, Bangalore, IndiaMario G. Alma4Broncopneumologia e Tisiologia, Azienda Ospedaliera San Camillo Forlanini, Rome, ItalyVittorio Colizzi8Dept of Biology, University of Rome “Tor Vergata”, Rome, ItalyGerhard Walzl6SA MRC Centre for TB Research, DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South AfricaCesare Saltini1Dept of Biomedicine and Prevention, University of Rome “Tor Vergata”, Rome, ItalyJeff Boyle2QIAGEN Sciences LLC, Germantown, MD, USAMassimo Amicosante1Dept of Biomedicine and Prevention, University of Rome “Tor Vergata”, Rome, Italy
- QuantiFERON-TB performance enhanced by novel Mycobacterium tuberculosis-specific antigensBy Monica Losi, Ashley J. Knights, Francesca Mariani, Alfonso M. Altieri, Gregorino Paone, Andre G. Loxton, Novel N. Chegou, John Kenneth, Mario G. Alma, Vittorio Colizzi, Gerhard Walzl, Cesare Saltini, Jeff Boyle and Massimo AmicosanteMonica Losi1Dept of Biomedicine and Prevention, University of Rome “Tor Vergata”, Rome, ItalyAshley J. Knights2QIAGEN Sciences LLC, Germantown, MD, USAFrancesca Mariani3Institute of Cell Biology and Neurobiology, National Research Council, Rome, ItalyAlfonso M. Altieri4Broncopneumologia e Tisiologia, Azienda Ospedaliera San Camillo Forlanini, Rome, ItalyGregorino Paone5Dept of Cardiovascular, Respiratory, Nephrologic, Anesthesiologic and Geriatric Sciences, University of Rome “La Sapienza”, Rome, ItalyAndre G. Loxton6SA MRC Centre for TB Research, DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South AfricaNovel N. Chegou6SA MRC Centre for TB Research, DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South AfricaJohn Kenneth7Division of Infectious Diseases, St John's Research Institute, St John's National Academy of Health Sciences, Bangalore, IndiaMario G. Alma4Broncopneumologia e Tisiologia, Azienda Ospedaliera San Camillo Forlanini, Rome, ItalyVittorio Colizzi8Dept of Biology, University of Rome “Tor Vergata”, Rome, ItalyGerhard Walzl6SA MRC Centre for TB Research, DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South AfricaCesare Saltini1Dept of Biomedicine and Prevention, University of Rome “Tor Vergata”, Rome, ItalyJeff Boyle2QIAGEN Sciences LLC, Germantown, MD, USAMassimo Amicosante1Dept of Biomedicine and Prevention, University of Rome “Tor Vergata”, Rome, Italy
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.
